Update: TriSalus Life Sciences Shares Rise After Receiving FDA Clearance for TriNav Advance

02:21 PM EDT, 09/23/2026 (MT Newswires) -- (Updates with the latest stock move in the headline and the first paragraph.) TriSalus Life Sciences (TLSI) shares were up 5.9% in Wednesday trading after the company said late Tuesday it received US Food and Drug Administration clearance for TriNav Advance, the newest addition to its Pressure-Enabled Drug Delivery portfolio. TriNav Advance provides access to small, distal vessels via a compatible delivery microcatheter, the company said. The company said it plans to initiate a limited market release of the TriNav Advance device over the coming weeks. Price: 5.22, Change: +0.29, Percent Change: +5.88